Results 41 to 50 of about 992,417 (341)
Retinal micro-vascular and aortic macro-vascular changes in postmenopausal women with primary hyperparathyroidism [PDF]
, 2018 Aim of the study was to evaluate the micro and macro-vascular changes in patients with primary hyperparathyroidism (PHPT) compared to controls. 30 postmenopausal PHPT women (15 hypertensive and 15 normotensive) and 30 normotensive controls underwent ...
Biamonte, Federica +8 more
core +2 more sources
IEEE/ASME transactions on mechatronics, 2020 Retinal vein of the most common causes of vision loss, occurring when a blood clot or other obstruction occludes a retinal vein. A potential remedy for retinal vein occlusion is retinal vein cannulation, a surgical procedure that involves infusing the ...
M. Gerber, J. Hubschman, T. Tsao
semanticscholar +1 more source
Central retinal vein occlusion associated with platelet activation
Therapeutic Advances in Ophthalmology, 2019 Purpose: The aim of this article is to determine and compare the platelet activation by three main platelet activation parameters: mean platelet volume, platelet distribution width, and plateletcrit in patients with central retinal vein occlusion and ...
Mehmet Citirik
doaj +1 more source
MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT OF RETINAL VEIN OCCLUSION
Сибирский научный медицинский журнал, 2019 Retinal vein occlusion is the one of the most common diseases, which amounts to 60 % of all acute vascular ocular pathology, and takes second place in the severity of retinal lesions and prognosis after diabetic retinopathy.
P. L. Volodin +2 more
doaj +1 more source
Diagnostics, 2023 Aim: The primary goal of this study was to evaluate the reduction in non-perfusion area and improvement in blood flow as well as the reduction in retinal edema on optical coherence tomography angiography (OCT-A) in patients with retinal vein occlusion ...
Dorota Śpiewak +3 more
doaj +1 more source
Ocriplasmin in the treatment of vitreomacular traction in a patient with central retinal vein occlusion. a case report [PDF]
, 2018 Aim: To investigate the efficacy of intravitreal injection of ocriplasmin (JETREA®) in the treat-ment of vitreomacular traction (VMT). Materials and Methods: An 81-year-old man with VMT associated with central retinal vein occlusion in his left eye, was ...
Antonio Esposito, Raffaele +3 more
core +2 more sources
Acta ophthalmologica, 2020 To evaluate the safety and feasibility of robot‐assisted retinal vein cannulation with Ocriplasmin infusion for central retinal vein occlusion.
K. Willekens +7 more
semanticscholar +1 more source
Retinal vein thrombosis and risk of occult cancer: A nationwide cohort study
Cancer Medicine, 2018 Background Retinal vein thrombosis has in case reports been reported a clinical sign of cancer, especially hematological cancer. However, it is unclear whether retinal vein thrombosis is a marker of underlying cancer, as is the case for deep venous ...
Anette Tarp Hansen +4 more
doaj +1 more source
The new complex method of treatment central retinal veinand branch of retinal vein occlusion
Бюллетень сибирской медицины, 2008 The new treatment method of central retinal vein and branch of retinal vein occlusion, consisting of epiretinal injection of gemasa combined with standard pharmacotherapy was developed.
D. V. Petrachkov
doaj +1 more source
Widening use of dexamethasone implant for the treatment of macular edema [PDF]
, 2017 Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T. +9 more
core +2 more sources